ClariVest Asset Management LLC raised its stake in shares of Olema Pharmaceuticals, Inc. (NASDAQ:OLMA – Free Report) by 23.9% in the third quarter, according to its most recent 13F filing with the SEC. The fund owned 65,900 shares of the company’s stock after buying an additional 12,700 shares during the period. ClariVest Asset Management LLC […]
ClariVest Asset Management LLC acquired a new position in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Free Report) in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 33,304 shares of the biopharmaceutical company’s stock, valued at approximately $694,000. A number of other hedge funds have also […]
Agios Pharmaceuticals (NASDAQ:AGIO – Free Report) had its price objective lowered by Royal Bank of Canada from $43.00 to $42.00 in a research note released on Friday morning, Benzinga reports. The brokerage currently has an outperform rating on the biopharmaceutical company’s stock. AGIO has been the subject of a number of other reports. The Goldman […]
Clearstead Advisors LLC bought a new position in Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA – Free Report) during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm bought 5,064 shares of the biotechnology company’s stock, valued at approximately $57,000. Other institutional investors and hedge funds have […]
Nordea Investment Management AB trimmed its holdings in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) by 0.1% during the third quarter, Holdings Channel.com reports. The fund owned 338,443 shares of the company’s stock after selling 349 shares during the quarter. Nordea Investment Management AB’s holdings in Amphastar Pharmaceuticals were worth $15,700,000 as of […]